RBC Bioscience's latest marketcap:
As of 08/11/2025, RBC Bioscience's market capitalization has reached $8.11 M. According to our data, RBC Bioscience is the 42014th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 8.11 M |
| Revenue (ttm) | 6.86 M |
| Net Income (ttm) | 720,740.59 |
| Shares Out | 14.27 M |
| EPS (ttm) | 0.05 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 09/19/2024 |
| Earnings Date | 08/11/2025 |
RBC Bioscience's yearly market capitalization.
| Date | Market Cap(NT$) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/11/2025 | NT$242.64 M | $8.11 M | -0.26% | 42014 |
| 12/31/2024 | NT$247.83 M | $7.55 M | 17.9% | 39283 |
| 12/29/2023 | NT$210.2 M | $6.84 M | 2.21% | 38632 |
| 12/30/2022 | NT$205.66 M | $6.71 M | -55.24% | 37337 |
| 12/30/2021 | NT$459.45 M | $16.57 M | 33587 |
Company Profile
About RBC Bioscience Corporation
RBC Bioscience Corporation is a leading company specializing in the research, development, manufacturing, and distribution of life science and molecular diagnostic reagents and devices. Operating globally, the company serves markets in Europe, the United States, Asia, Taiwan, Africa, and Australia.
Product Offerings
- Molecular biomedical diagnostic and research reagents
- Gene extraction automatic testing instruments and reagent tissues
- Automated nucleic acid extractors
- Nucleic acid extraction kits
Distribution and Background
The company distributes its products through a network of trusted distributors. Founded in 1995, RBC Bioscience Corporation is headquartered in New Taipei City, Taiwan.
Frequently Asked Questions
-
What is RBC Bioscience's (TPEX-6848) current market cap?As of 08/11/2025, RBC Bioscience (including the parent company, if applicable) has an estimated market capitalization of $8.11 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does RBC Bioscience (TPEX-6848) rank globally by market cap?RBC Bioscience global market capitalization ranking is approximately 42014 as of 08/11/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.